Quality risk management and considerations on evaluation of stem cell-derived pancreatic islet cell medicinal productsLIU Dan, LU Jia-qi, YIN Hui-fang et al.Chinese Journal of New Drugs2025, No.24002026-08Analysis of common issues in quality control and evaluation of mesenchymal cell therapeutic drugsWEI Wei, CHENG Su-yuan, HAN Dong-mei et al.Chinese Journal of New Drugs2025, No.24002026-08Comparison of dissolution profiles of carbamazepine tablets by paddle method and flow-through cell method and study on in vitro-in vivo correlationWU Bin, ZHU Xiao-yue, ZHU Xue-bin et al.Chinese Journal of New Drugs2026, No.05002026-08Study on prediction and evaluation method of quantitative structure-activity relationship hepatotoxicity of medicinal and food homologous substancesZHANG Xin-you, LI Ying, WU Di-yao et al.Chinese Journal of New Drugs2026, No.01002026-08Research on the application of big data in distribution of national drug reference standardsGAO Zhi-feng, LUO Chen, AN Ran et al.Chinese Journal of New Drugs2026, No.01002026-08Mechanism and clinical evaluation of a novel drug deuruxolitinib for treatment of alopecia areataQIAN Qing, DU Wen-lin, WANG QiangChinese Journal of New Drugs2026, No.01002026-08Establishment and analysis of the detection method for the target gene profile of miR-320 in Qingfei Paidu DecoctionWU Di-yao, LEI Jin-yue, ZHANG Xin-you et al.Chinese Journal of New Drugs2026, No.01002026-08Study on the simplified registration pathway for over-the-counter traditional Chinese medicinesMO Qi-hui, LI Ze-yu, LI Yuan-heng et al.Chinese Journal of New Drugs2026, No.01002026-08A perspective from generic drugs on typical cases under China's drug patent linkage systemSONG Jie-mei, WANG Hua-ping, XU DanChinese Journal of New Drugs2026, No.01002026-08Bioequivalence of clarithromycin tablets in Chinese healthy subjectsWANG Hua-wei, LI Xiao-bin, CAO Ying et al.Chinese Journal of New Drugs2026, No.01002026-08Advances in novel ocular drug delivery systemsBI Xiao-shuang, ZHAO Jian, JI Mu-se et al.Chinese Journal of New Drugs2026, No.03002026-08Efficacy and safety of vunakizumab versus other interleukin-17A inhibitors in the treatment of moderate-to-severe plaque psoriasis with matching-adjusted indirect comparisonsHE Xiao-ning, GENG Jia-lu, HAN Bing-linChinese Journal of New Drugs2026, No.03002026-08Signal mining and analysis of drug-induced hypotension in older patients based on FAERS databaseNI Wen-qi, ZHU Feng, ZHOU Shuang et al.Chinese Journal of New Drugs2026, No.04002026-08Quantitative determination of saponin components in Huoxue Zhitong Capsules using UHPLC-MS/MS coupled with multivariate statistical analysisNI Shi-sheng, LIN Yi-fan, HUANG Ming-qingChinese Journal of New Drugs2026, No.04002026-08Research on artificial intelligence detection method of few-shot oriented fine-grained black beans of different specifications and their confused and counterfeit productsSHI Jia, KANG Shuai, WANG Zi-jun et al.Chinese Journal of New Drugs2026, No.04002026-08Development of the first batch of saxagliptin monohydrate national control productZHAI Chen-fei, FENG Yu-fei, LUO Chen et al.Chinese Journal of New Drugs2026, No.05002026-08Comparative assessment of potential risks associated with variable fill volumes in biopharmaceutical glass injection vialsLI Xiao-yu, QI Yan-fei, YUAN Shu-sheng et al.Chinese Journal of New Drugs2026, No.05002026-08In vitro and in vivo antibacterial activity of compound L007-0069 against Staphylococcus epidermidis and its antibacterial mechanismYANG Wen-yi, TU Xi-chen, HOU Zheng-liChinese Journal of New Drugs2026, No.05002026-08Standardization of the first batch of national reference standard of lysozymeLIU Li-sha, HE Dong-mei, LI Jing et al.Chinese Journal of New Drugs2026, No.05002026-08Treatment patterns and economic burden of biologics in patients with moderate to severe psoriasisXU Xiao-yang, HE Xiao-ning, WU JingChinese Journal of New Drugs2026, No.06002026-08 